212 related articles for article (PubMed ID: 22221908)
1. Treatment of systemic sclerosis-associated calcinosis: a case report of rituximab-induced regression of CREST-related calcinosis and review of the literature.
Daoussis D; Antonopoulos I; Liossis SN; Yiannopoulos G; Andonopoulos AP
Semin Arthritis Rheum; 2012 Jun; 41(6):822-9. PubMed ID: 22221908
[TBL] [Abstract][Full Text] [Related]
2. Flare of calcinosis despite rituximab therapy.
Hurabielle C; Allanore Y; Kahan A; Avouac J
Semin Arthritis Rheum; 2014 Oct; 44(2):e5-6. PubMed ID: 24842570
[No Abstract] [Full Text] [Related]
3. Rituximab-induced regression of CREST-related calcinosis.
de Paula DR; Klem FB; Lorencetti PG; Muller C; Azevedo VF
Clin Rheumatol; 2013 Feb; 32(2):281-3. PubMed ID: 23179007
[TBL] [Abstract][Full Text] [Related]
4. Is rituximab an effective treatment of refractory calcinosis?
Dubos M; Ly K; Martel C; Fauchais AL
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27247203
[TBL] [Abstract][Full Text] [Related]
5. Systemic sclerosis and calcinosis cutis: response to rituximab.
Poormoghim H; Andalib E; Almasi AR; Hadibigi E
J Clin Pharm Ther; 2016 Feb; 41(1):94-6. PubMed ID: 26667314
[TBL] [Abstract][Full Text] [Related]
6. A case of a generalized symptomatic calcinosis in systemic sclerosis.
Jecan CR; Bedereag ŞI; Sinescu RD; Grigorean VT; Cozma CN; Bordianu A; Florescu IP
Rom J Morphol Embryol; 2016; 57(2 Suppl):865-869. PubMed ID: 27833984
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal hemorrhage in patients with systemic sclerosis and CREST syndrome.
Duchini A; Sessoms SL
Am J Gastroenterol; 1998 Sep; 93(9):1453-6. PubMed ID: 9732924
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of extracorporeal shock wave therapy (ESWT) in calcinosis cutis associated with systemic sclerosis.
Blumhardt S; Frey DP; Toniolo M; Alkadhi H; Held U; Distler O
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):177-180. PubMed ID: 27494629
[TBL] [Abstract][Full Text] [Related]
9. The effects of warfarin on calcinosis in a patient with systemic sclerosis.
Yoshida S; Torikai K
J Rheumatol; 1993 Jul; 20(7):1233-5. PubMed ID: 8371227
[TBL] [Abstract][Full Text] [Related]
10. Calcinosis cutis in autoimmune connective tissue diseases.
Gutierrez A; Wetter DA
Dermatol Ther; 2012; 25(2):195-206. PubMed ID: 22741938
[TBL] [Abstract][Full Text] [Related]
11. Cranial nerve VIII involvement in a patient with progressive systemic sclerosis.
Iskandar SB; Loyd S; Roy TM
Tenn Med; 2004 Mar; 97(3):117-9. PubMed ID: 15054944
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of subcutaneous calcinosis in systemic disorders].
Bienvenu B
Rev Med Interne; 2014 Jul; 35(7):444-52. PubMed ID: 24880741
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma and chronic myeloid leukemia: a sheer coincidence, a consequence of long lasting D-penicillamine therapy or a plausible relationship of both diseases?
Kaşifoğlu T; Korkmaz C; Yaşar S; Gülbaş Z
Rheumatol Int; 2006 Dec; 27(2):175-7. PubMed ID: 16871407
[TBL] [Abstract][Full Text] [Related]
14. Sjögren's syndrome in patients with the CREST variant of progressive systemic scleroderma.
Drosos AA; Pennec YL; Elisaf M; Lamour A; Acritidis NC; Jouquan JR; Moutsopoulos HM; Youinou P
J Rheumatol; 1991 Nov; 18(11):1685-8. PubMed ID: 1787489
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression?
Vayssairat M; Hidouche D; Abdoucheli-Baudot N; Gaitz JP
Ann Rheum Dis; 1998 Apr; 57(4):252-4. PubMed ID: 9709184
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of rituximab for the treatment of refractory systemic sclerosis associated calcinosis: A case series and systematic review of the literature.
Narváez J; Pirola JP; LLuch J; Juarez P; Nolla JM; Valenzuela A
Autoimmun Rev; 2019 Mar; 18(3):262-269. PubMed ID: 30639647
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary hypertension in diffuse scleroderma and the CREST syndrome].
Presetnik M; Music E; Kolsek B; Rozman B
Plucne Bolesti; 1989; 41(1-2):5-7. PubMed ID: 2798573
[TBL] [Abstract][Full Text] [Related]
18. Low dose warfarin treatment for calcinosis in patients with systemic sclerosis.
Cukierman T; Elinav E; Korem M; Chajek-Shaul T
Ann Rheum Dis; 2004 Oct; 63(10):1341-3. PubMed ID: 15361398
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment in calcinosis cutis associated with connective-tissue diseases.
Dima A; Balanescu P; Baicus C
Rom J Intern Med; 2014; 52(2):55-67. PubMed ID: 25338341
[TBL] [Abstract][Full Text] [Related]
20. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
